Search
Returning search results with filters:
Remove filter for
Category: Drugs
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 46 - 60 of 290 items.
ZEJULA (niraparib) - Update on the Maintenance Treatment in Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in the Second or Later Line Setting
AlertHealth professional risk communication | 2023-02-16
Unauthorized products may pose serious health risks (June 16, 2022 to February 10, 2023)
AlertPublic advisory | 2023-02-10
Amitriptyline antidepressant drugs recalled because of a nitrosamine impurity
AlertPublic advisory | 2023-02-07
RUZURGI (amifampridine) - Authorization Status
AlertHealth professional risk communication | 2023-01-20
Unauthorized health products removed from sale from More to Shoppe Facebook store and its Edson, Alberta, warehouse
AlertPublic advisory | 2023-01-20
OCALIVA (obeticholic acid) – New Contraindication for the Treatment of Primary Biliary Cholangitis (PBC)
AlertHealth professional risk communication | 2022-12-05
Canadian labelling for all JAK inhibitors to include risks of serious heart-related problems, fatal blood clots and cancer
AlertPublic advisory | 2022-11-01
Janus Kinase Inhibitors and the Risk of Major Adverse Cardiovascular Events, Thrombosis (Including Fatal Events) and Malignancy
AlertHealth professional risk communication | 2022-10-31
Children’s ibuprofen/acetaminophen shortage: What you should know and do
AlertPublic advisory | 2022-10-07
Counterfeit Nuceiva injectable drug seized from New You Spa in Vaughan, Ontario
AlertPublic advisory | 2022-09-06
IMBRUVICA (ibrutinib) - Risk of Serious and Fatal Cardiac Arrhythmias or Cardiac Failure
AlertHealth professional risk communication | 2022-08-29
Recall of one lot of Jamp-Atorvastatin Calcium as some bottles may be labelled as containing 10 mg tablets, but contain 40 mg tablets
AlertPublic advisory | 2022-08-27
Counterfeit Viagra and Cialis erectile dysfunction drugs seized from Grace Daily Mart in Scarborough, Ontario
AlertPublic advisory | 2022-08-25
Recall of one lot of pms-Hydromorphone due to packaging error that could potentially lead to overdose
AlertPublic advisory | 2022-08-20
Taro-Zoledronic acid injection drug, used for osteoporosis and Page's disease, recalled because it may contain particulate matter
AlertPublic advisory | 2022-08-09